MX2020012810A - Formulación de nicotina. - Google Patents
Formulación de nicotina.Info
- Publication number
- MX2020012810A MX2020012810A MX2020012810A MX2020012810A MX2020012810A MX 2020012810 A MX2020012810 A MX 2020012810A MX 2020012810 A MX2020012810 A MX 2020012810A MX 2020012810 A MX2020012810 A MX 2020012810A MX 2020012810 A MX2020012810 A MX 2020012810A
- Authority
- MX
- Mexico
- Prior art keywords
- nicotine formulation
- nicotine
- formulation
- relates
- via inhalation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0085—Inhalators using ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Manufacture Of Tobacco Products (AREA)
Abstract
La invención se refiere a una formulación farmacéutica que comprende nicotina; la formulación puede ser dispersa en un gas a temperatura ambiente para su suministro por medio de inhalación; la invención se refiere también a un método de suministro de nicotina a un sujeto por medio de inhalación, y específicamente por medio del uso de un nebulizador.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18175640.4A EP3574902A1 (en) | 2018-06-01 | 2018-06-01 | Nicotine formulation and mode of delivery |
PCT/EP2019/064212 WO2019229249A1 (en) | 2018-06-01 | 2019-05-31 | Nicotine formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020012810A true MX2020012810A (es) | 2022-03-08 |
Family
ID=62528283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020012810A MX2020012810A (es) | 2018-06-01 | 2019-05-31 | Formulación de nicotina. |
Country Status (13)
Country | Link |
---|---|
US (2) | US11833145B2 (es) |
EP (3) | EP3574902A1 (es) |
JP (1) | JP7224375B2 (es) |
CN (1) | CN112218637A (es) |
AU (2) | AU2019276357B2 (es) |
BR (1) | BR112020024088B1 (es) |
CA (1) | CA3099940A1 (es) |
ES (1) | ES2883799T3 (es) |
MA (2) | MA54714A (es) |
MX (1) | MX2020012810A (es) |
PL (1) | PL3684362T3 (es) |
SG (1) | SG11202011761XA (es) |
WO (1) | WO2019229249A1 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3574902A1 (en) * | 2018-06-01 | 2019-12-04 | Yatzz Limited | Nicotine formulation and mode of delivery |
GB201817868D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolised formulation |
GB201817859D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
GB201817860D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolised formulation |
GB201817867D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
GB201817865D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
GB201817863D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
FR3102041A1 (fr) * | 2019-10-22 | 2021-04-23 | Aroma Sens | Edulcorant pour liquides de cigarette électronique |
US11730193B2 (en) | 2019-12-15 | 2023-08-22 | Shaheen Innovations Holding Limited | Hookah device |
EP3860696B1 (en) | 2019-12-15 | 2024-04-10 | Shaheen Innovations Holding Limited | Ultrasonic mist inhaler |
US11666713B2 (en) | 2019-12-15 | 2023-06-06 | Shaheen Innovations Holding Limited | Mist inhaler devices |
WO2021123867A1 (en) | 2019-12-15 | 2021-06-24 | Shaheen Innovations Holding Limited | Ultrasonic mist inhaler |
US20240148053A9 (en) | 2019-12-15 | 2024-05-09 | Shaheen Innovations Holding Limited | Hookah device |
IL294000B (en) | 2019-12-15 | 2022-09-01 | Shaheen Innovations Holding Ltd | Steam inhaler devices |
WO2021123869A1 (en) | 2019-12-15 | 2021-06-24 | Shaheen Innovations Holding Limited | Ultrasonic mist inhaler |
US11730191B2 (en) | 2019-12-15 | 2023-08-22 | Shaheen Innovations Holding Limited | Hookah device |
US11589610B2 (en) | 2019-12-15 | 2023-02-28 | Shaheen Innovations Holding Limited | Nicotine delivery device having a mist generator device and a driver device |
EP4076025A1 (en) * | 2019-12-18 | 2022-10-26 | Philip Morris Products, S.A. | A formulation for use in an aerosol-generating system |
JP2021122237A (ja) * | 2020-02-05 | 2021-08-30 | 日本たばこ産業株式会社 | 液体加熱式の加熱型香味吸引器用の液体組成物 |
US20230107605A1 (en) | 2020-03-27 | 2023-04-06 | Mcneil Ab | Cartridge with nicotine |
WO2022129907A1 (en) * | 2020-12-15 | 2022-06-23 | Shaheen Innovations Holding Limited | Mist inhaler devices |
MA65146B1 (fr) * | 2020-04-06 | 2024-05-31 | Shaheen Innovations Holding Ltd | Dispositifs d'inhalateur de brouillard |
CN111802686A (zh) * | 2020-07-27 | 2020-10-23 | 湖北中烟工业有限责任公司 | 含脂肪酸、植物油的雾化剂以及加热不燃烧卷烟 |
CN111855866A (zh) * | 2020-08-25 | 2020-10-30 | 甘肃烟草工业有限责任公司 | 一种快速测定烟用添加剂中甲醛的方法 |
CN113197330A (zh) * | 2021-04-28 | 2021-08-03 | 深圳市博睿生物科技有限公司 | 一种电子烟新型甜味剂及制备方法及应用 |
IL283002A (en) * | 2021-05-06 | 2022-12-01 | Nicogen Ltd | Nicotine formulations and aerosols |
CN113912585B (zh) * | 2021-11-09 | 2023-02-24 | 深圳萨特瓦生物科技有限公司 | 复合尼古丁盐及其制备方法与应用、电子烟油及电子烟 |
US20230188901A1 (en) | 2021-12-15 | 2023-06-15 | Shaheen Innovations Holding Limited | Apparatus for transmitting ultrasonic waves |
CN116019250A (zh) * | 2022-12-22 | 2023-04-28 | 东莞市吉纯生物技术有限公司 | 基于酸性电解水的雾化液、制备方法和酸性电解水制备方法 |
WO2024138377A1 (zh) * | 2022-12-27 | 2024-07-04 | 思摩尔国际控股有限公司 | 一种雾化液、雾化器及电子雾化装置 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8301659D0 (en) * | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
GB2133691B (en) * | 1983-01-21 | 1986-05-21 | Leo Ab | Smoking substitutes for nasal administration |
CA2231968A1 (en) * | 1998-03-11 | 1999-09-11 | Smoke-Stop, A Partnership Consisting Of Art Slutsky | Method of producing a nicotine medicament |
US7767698B2 (en) * | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
SE0201669D0 (sv) * | 2002-06-03 | 2002-06-03 | Pharmacia Ab | New formulation and use thereof |
GB0712308D0 (en) * | 2007-06-25 | 2007-08-01 | Kind Group Ltd | An inhalable composition |
CN114223928A (zh) * | 2013-05-06 | 2022-03-25 | 尤尔实验室有限公司 | 用于气溶胶装置的烟碱盐调配物及其方法 |
UA122320C2 (uk) * | 2013-07-19 | 2020-10-26 | Олтріа Клайєнт Сервісиз Ллк | Рідка аерозольна композиція для електронного курильного виробу |
DE102015117811A1 (de) * | 2015-10-20 | 2017-04-20 | Chv Pharma Gmbh & Co. Kg | Inhalator sowie wirkstoffhaltige Zubereitung für einen Inhalator |
EP3574902A1 (en) * | 2018-06-01 | 2019-12-04 | Yatzz Limited | Nicotine formulation and mode of delivery |
-
2018
- 2018-06-01 EP EP18175640.4A patent/EP3574902A1/en not_active Withdrawn
-
2019
- 2019-05-31 MX MX2020012810A patent/MX2020012810A/es unknown
- 2019-05-31 AU AU2019276357A patent/AU2019276357B2/en active Active
- 2019-05-31 US US17/057,700 patent/US11833145B2/en active Active
- 2019-05-31 EP EP21174043.6A patent/EP3909581A1/en active Pending
- 2019-05-31 JP JP2020567039A patent/JP7224375B2/ja active Active
- 2019-05-31 SG SG11202011761XA patent/SG11202011761XA/en unknown
- 2019-05-31 MA MA054714A patent/MA54714A/fr unknown
- 2019-05-31 CN CN201980034986.5A patent/CN112218637A/zh active Pending
- 2019-05-31 EP EP19727687.6A patent/EP3684362B1/en active Active
- 2019-05-31 BR BR112020024088-5A patent/BR112020024088B1/pt active IP Right Grant
- 2019-05-31 CA CA3099940A patent/CA3099940A1/en active Pending
- 2019-05-31 WO PCT/EP2019/064212 patent/WO2019229249A1/en active Application Filing
- 2019-05-31 PL PL19727687T patent/PL3684362T3/pl unknown
- 2019-05-31 ES ES19727687T patent/ES2883799T3/es active Active
- 2019-05-31 MA MA50205A patent/MA50205B1/fr unknown
-
2023
- 2023-05-08 AU AU2023202855A patent/AU2023202855A1/en active Pending
- 2023-10-26 US US18/495,012 patent/US20240050424A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20240050424A1 (en) | 2024-02-15 |
MA54714A (fr) | 2021-11-17 |
BR112020024088B1 (pt) | 2022-10-11 |
CA3099940A1 (en) | 2019-12-05 |
SG11202011761XA (en) | 2020-12-30 |
EP3684362A1 (en) | 2020-07-29 |
EP3574902A1 (en) | 2019-12-04 |
US11833145B2 (en) | 2023-12-05 |
ES2883799T3 (es) | 2021-12-09 |
MA50205A (fr) | 2020-07-29 |
WO2019229249A1 (en) | 2019-12-05 |
EP3684362B1 (en) | 2021-06-23 |
CN112218637A (zh) | 2021-01-12 |
AU2023202855A1 (en) | 2023-05-25 |
BR112020024088A2 (pt) | 2021-02-17 |
JP7224375B2 (ja) | 2023-02-17 |
JP2021526147A (ja) | 2021-09-30 |
EP3909581A1 (en) | 2021-11-17 |
AU2019276357B2 (en) | 2023-04-20 |
AU2019276357A1 (en) | 2020-11-26 |
MA50205B1 (fr) | 2021-09-30 |
US20210196700A1 (en) | 2021-07-01 |
PL3684362T3 (pl) | 2021-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020012810A (es) | Formulación de nicotina. | |
ZA202000494B (en) | Nicotine salts and methods of making and using same | |
MX2021008564A (es) | Formulaciones de sal de nicotina para dispositivos de aerosol y metodos de los mismos. | |
MX2023002250A (es) | Formulacion liquida de nicotina para dispositivos en aerosol y metodos de los mismos. | |
MX2016015179A (es) | Una formulación líquida que comprende nicotina para administracion en aerosol. | |
EP3697481A4 (en) | NASAL DRUG DELIVERY DEVICE AND METHOD OF USE | |
PH12018502738A1 (en) | Compositions, devices, and methods for the treatment of alcohol use disorder | |
PH12018502109A1 (en) | Medicine obtained by combining fxr agonist and arb | |
PH12015502593A1 (en) | COMPOSITIONS, METHODS and SYSTEMS FOR RESPIRATORY DELIVERY OF THREE OR MORE ACTIVE AGENTS | |
MY176176A (en) | Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation | |
MY191380A (en) | Stabilized fixed dose drug composition having mometasone and olopatadine | |
PH12018500544A1 (en) | Inhalable nicotine formulations, and methods of making and using thereof | |
PH12017501486A1 (en) | Nasal powder formulation for treatment of hypoglycemia | |
MX335944B (es) | Composiciones que comprenden sulfato de salbutamol. | |
MX2016005232A (es) | Formulaciones liposomicas para inhalacion, modificadas con agente tensoactivo, que proveen un perfil de liberacion tanto inmediata como sostenida. | |
MX2015014513A (es) | Composicion que comprende sulfato de salbutamol. | |
MX2017003561A (es) | Composiciones y metodos para revestimientos cannabinoides para su uso en la administracion de farmacos. | |
MX2019010263A (es) | Formulaciones de nicotina inhalables y metodos de fabricacion y uso de las mismas. | |
MX2023003230A (es) | Procesos e intermediario para la preparacion a gran escala de hemisuccinato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbon il)-piridin-2-il]-benzamida y preparacion de acetato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il ]-benzamida. | |
MX2017013950A (es) | Polvos de zolmitriptán para suministro pulmonar. | |
MX2015009891A (es) | Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion. | |
EP3661576A4 (en) | MEDICAL NEBULIZER FOR RAPID DRUG DELIVERY | |
MX2019004736A (es) | Mini-tabletas de melatonina y metodos de fabricacion de las mismas. | |
EP3703659A4 (en) | SYSTEMS, APPARATUS AND METHODS FOR DELIVERY OF THERAPEUTIC SUBSTANCE TO THE NASAL CAVITY | |
WO2015130963A3 (en) | Compositions and methods for administering insulin or insulin-like protein to the brain |